SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000947871-24-000768
Filing Date
2024-09-23
Accepted
2024-09-23 16:42:23
Documents
1
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 7130
  Complete submission text file 0000947871-24-000768.txt   9562
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 241316656

Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629 (212) 739-6400
OrbiMed Capital GP VIII LLC (Reporting) CIK: 0001845804 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 241316655